Debanjan Ray - Net Worth and Insider Trading
Debanjan Ray Net Worth
The estimated net worth of Debanjan Ray is at least $6,462 dollars as of 2024-11-10. Debanjan Ray is the CFO of CytomX Therapeutics Inc and owns about 5,928 shares of CytomX Therapeutics Inc (CTMX) stock worth over $6,462. Details can be seen in Debanjan Ray's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Debanjan Ray has not made any transactions after 2018-12-12 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Debanjan Ray
Debanjan Ray Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Debanjan Ray owns 1 companies in total, including CytomX Therapeutics Inc (CTMX) .
Click here to see the complete history of Debanjan Ray’s form 4 insider trades.
Insider Ownership Summary of Debanjan Ray
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CTMX | CytomX Therapeutics Inc | 2018-12-12 | Chief Financial Officer |
Debanjan Ray Latest Holdings Summary
Debanjan Ray currently owns a total of 1 stock. Debanjan Ray owns 5,928 shares of CytomX Therapeutics Inc (CTMX) as of December 12, 2018, with a value of $6,462.
Latest Holdings of Debanjan Ray
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CTMX | CytomX Therapeutics Inc | 2018-12-12 | 5,928 | 1.09 | 6,462 |
Holding Weightings of Debanjan Ray
Debanjan Ray Form 4 Trading Tracker
According to the SEC Form 4 filings, Debanjan Ray has made a total of 0 transactions in CytomX Therapeutics Inc (CTMX) over the past 5 years. The most-recent trade in CytomX Therapeutics Inc is the sale of 3,000 shares on December 12, 2018, which brought Debanjan Ray around $45,000.
Insider Trading History of Debanjan Ray
- 1
Debanjan Ray Trading Performance
Debanjan Ray Ownership Network
Ownership Network List of Debanjan Ray
Ownership Network Relation of Debanjan Ray
Debanjan Ray Owned Company Details
What does CytomX Therapeutics Inc do?
Who are the key executives at CytomX Therapeutics Inc?
Debanjan Ray is the Chief Financial Officer of CytomX Therapeutics Inc. Other key executives at CytomX Therapeutics Inc include SVP & Chief Scientific Officer Marcia Belvin , SVP & Finance and Accounting Christopher Ogden , and Chief Financial Officer Jeffrey B Landau .
CytomX Therapeutics Inc (CTMX) Insider Trades Summary
Over the past 18 months, Debanjan Ray made no insider transaction in CytomX Therapeutics Inc (CTMX). Other recent insider transactions involving CytomX Therapeutics Inc (CTMX) include a net sale of 62,273 shares made by Sean A. Mccarthy , a net sale of 25,172 shares made by Marcia Belvin , and a net sale of 19,012 shares made by Lloyd A Rowland .
In summary, during the past 3 months, insiders sold 28,425 shares of CytomX Therapeutics Inc (CTMX) in total and bought 0 shares, with a net sale of 28,425 shares. During the past 18 months, 132,341 shares of CytomX Therapeutics Inc (CTMX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 132,341 shares.
CytomX Therapeutics Inc (CTMX)'s detailed insider trading history can be found in Insider Trading Tracker table.
CytomX Therapeutics Inc Insider Transactions
Debanjan Ray Mailing Address
Above is the net worth, insider trading, and ownership report for Debanjan Ray. You might contact Debanjan Ray via mailing address: C/o Cytomx Therapeutics, Inc., 151 Oyster Point Blvd, Suite 400, South San Francisco Ca 94080.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
